Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|October 30, 2001
Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusionS Sangwan, J M Agosti, L A Bauer, et al.The American Review of Respiratory Disease|July 1, 1989
Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitroG H Ayars, L C Altman, M M McManus, et al.Clinical Immunology and Immunopathology|January 1, 1990
A selective defect in tissue factor mRNA expression in monocytes from AIDS patientsJ L Lathey, J M Agosti, J A Nelson, et al.Journal of Clinical Immunology|April 26, 2001
Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvantR J Looney, M S Hasan, D Coffin, et al.The Journal of Infectious Diseases|September 9, 1999
The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trialG Skowron, D Stein, G Drusano, et al.The New England Journal of Medicine|June 27, 1996
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study GroupC J Fisher, J M Agosti, S M Opal, et al.The Journal of Infectious Diseases|October 7, 2000
A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDSC Brites, M J Gilbert, D Pedral-Sampaio, et al.Blood|May 15, 1997
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humansT van der Poll, S M Coyle, M Levi, et al.American Journal of Surgery|September 1, 1996
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgeryN J Meropol, N J Petrelli, B J Lipman, et al.Pageof 3